Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin

The approval of histone deacetylase inhibitors for treatment of lymphoma subtypes has positioned histone modifications as potential targets for the development of new classes of anticancer drugs. Histones also undergo phosphorylation events, and Haspin is a protein kinase the only known target of wh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Huertas, D, Soler, M, Moreto, J, Villanueva, A, Martinez, A, Vidal, A, Charlton, M, Moffat, D, Patel, S, McDermott, J, Owen, J, Brotherton, D, Krige, D, Cuthill, S, Esteller, M
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2012
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3312407/
https://ncbi.nlm.nih.gov/pubmed/21804608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.335
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge